Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 6401 - 6408 of 12099 results

Sued Customers Insufficient to Prove a Supplier’s Actual Case or Controversy Against Patentee

January 30, 2018| Blog| Viewpoint

Law360 Names Attys Who Moved Up The Firm Ranks In Q4

January 30, 2018| News

Preparation for 2017 Fiscal Year-End SEC Filings and 2018 Annual Shareholder Meetings

January 30, 2018| Advisory| Viewpoint

MintzEdge 101: Getting Your Financial House in Order - Walter Tendler (Mission Ventures)

January 30, 2018| Podcast| Viewpoint

Governor Baker Files FY2019 Budget

January 30, 2018| Alert| Viewpoint

Energy & Sustainability 2017 Year in Review: Milestones (Part 2 of 4)

January 29, 2018| Blog| Viewpoint

ML Strategies Health Care Preview - Week of January 29th

January 29, 2018| Blog| Viewpoint

Key Legal Issues for Esports Player Agreements

January 29, 2018| News

News & Press Releases

Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement

August 18, 2025

Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.

Mintz Advises the Underwriters in Ondas Holdings’ $173 Million Public Offering

August 18, 2025

Mintz advised the underwriters in connection with the $173 million public offering by Ondas Holdings Inc. of 53,084,000 shares of its common stock, which includes 6,924,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.

Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE

August 15, 2025

Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.

View all News and Press Releases